Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi M Carter

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Breast Cancer Research : BCR|April 30, 2021
Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancerJuanjuan Gu, Eric C Polley, Max Denis, et al.
Annals of Surgical Oncology|July 7, 2017
Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant RadiotherapyJaime M Glorioso, Alexandra B Gonzalez Juarrero, Brian R Rodysill, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
ERβ expression and breast cancer risk prediction for women with atypiasTina J Hieken, Jodi M Carter, John R Hawse, et al.
Breast Cancer Research and Treatment|October 2, 2019
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissuesJohn R Hawse, Jodi M Carter, Kirsten G M Aspros, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Cancers|September 9, 2022
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast CancerIshwar N Kohale, Jia Yu, Yongxian Zhuang, et al.
The American Journal of Surgical Pathology|August 16, 2016
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 PatientsAlyaa Al-Ibraheemi, Carrie Y Inwards, Riyam T Zreik, et al.
The American Journal of Surgical Pathology|October 11, 2018
Recurrent Genomic Alterations in Soft Tissue PerineuriomasJodi M Carter, Yanhong Wu, Melissa M Blessing, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 24, 2017
Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast DiseaseJodi M Carter, Tanya L Hoskin, M Alvaro Pena, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Breast Cancer Research : BCR|April 30, 2021
Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancerJuanjuan Gu, Eric C Polley, Max Denis, et al.
Annals of Surgical Oncology|July 7, 2017
Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant RadiotherapyJaime M Glorioso, Alexandra B Gonzalez Juarrero, Brian R Rodysill, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
ERβ expression and breast cancer risk prediction for women with atypiasTina J Hieken, Jodi M Carter, John R Hawse, et al.
Breast Cancer Research and Treatment|October 2, 2019
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissuesJohn R Hawse, Jodi M Carter, Kirsten G M Aspros, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Cancers|September 9, 2022
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast CancerIshwar N Kohale, Jia Yu, Yongxian Zhuang, et al.
The American Journal of Surgical Pathology|August 16, 2016
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 PatientsAlyaa Al-Ibraheemi, Carrie Y Inwards, Riyam T Zreik, et al.
The American Journal of Surgical Pathology|October 11, 2018
Recurrent Genomic Alterations in Soft Tissue PerineuriomasJodi M Carter, Yanhong Wu, Melissa M Blessing, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 24, 2017
Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast DiseaseJodi M Carter, Tanya L Hoskin, M Alvaro Pena, et al.
Pageof 12